Pro Feature
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moPRAZIQUANTEL (praziquantel) by Pfizer is 12. Approved for older for the treatment of the following infections: schistosomiasis due to all species of schistosoma (for example, schistosoma mekongi, schistosoma japonicum and 6 more indications. First approved in 2017.
Drug data last refreshed 19h ago
12.1 Mechanism of Action Praziquantel is an anthelmintic drug [see ] . 12.3 Pharmacokinetics Absorption After oral administration, 80% of an administered praziquantel dose is absorbed, with maximal serum concentrations of praziquantel achieved 1 to 3 hours after dosing. Elimination Following oral…
Worked on PRAZIQUANTEL at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Anthelmintic
Treatment of Clonorchiasis in Guangxi With Albendazole, Tribendimidine, and Praziquantel
Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis
Praziquantel in Children Under Age 4
Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study
Praziquantel Bioequivalence Study
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/mo